JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 31 No. 12 1980-1985
© 1990 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peters, A.M.
Right arrow Articles by Allison, D.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peters, A.M.
Right arrow Articles by Allison, D.J.

Noninvasive Measurement of Renal Blood Flow with Technetium-99m-DTPA in the Evaluation of Patients with Suspected Renovascular Hypertension

A.M. Peters, J. Brown, D. Crossman, A.J. Brady, A.P. Hemingway, M.E. Roddie and D.J. Allison

Departments of Diagnostic Radiology and Clinical Pharmacology, Hammersmith Hospital, London, England

Correspondence: For reprints contact: A.M. Peters, Department of Diagnostic Radiology, Hammersmith Hospital, Du Cane Rd., London W12 OHS.

ABSTRACT

If a hypertensive patient with renal artery stenosis (RAS) is to benefit from percutaneous transluminal renal angioplasty (PTRA) in terms of a sustained improvement in blood pressure control, one may postulate a demonstrable reduction in renal blood flow (RBF) to that kidney, reversible by PTRA. In a population of 32 hypertensive patients, RAS was present in 23 of 62 kidneys. Eleven of the 32 patients underwent renal revascularization, of whom 6 showed improvement in blood pressure control at 6 mo, i.e., had renovascular hypertension (RVH). There was no correlation between RBF and angiographic appearances of the renal artery. Furthermore, there was no significant difference between RBF in the stenosed kidneys of the patients with RVH compared with the stenosed kidneys of patients without RVH. Individual kidney RBF was 22% (s.d. 11) higher 1–3 wk after PTRA but the increase did not correlate with clinical outcome. Angiotensin converting enzyme (ACE) inhibition increased RBF by 25% (s.d. 25) of baseline flow before PTRA but the increase did not correlate with clinical outcome. Measurement of RBF is of limited value for the prediction of the long-term blood pressure response following PTRA.




This article has been cited by other articles:


Home page
Br. J. Radiol.Home page
T C Gill-Leertouwer, E J Gussenhoven, J Deinum, L C van Dijk, and P M T Pattynama
Shrinkage of the distal renal artery 1 year after stent placement as evidenced with serial intravascular ultrasound
Br. J. Radiol., November 1, 2002; 75(899): 879 - 883.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
J.-F. Paul, P. Ugolini, M. Sapoval, E. Mousseaux, and J.-C. Gaux
Unilateral Renal Artery Stenosis: Perfusion Patterns with Electron-Beam Dynamic CT—Preliminary Experience
Radiology, October 1, 2001; 221(1): 261 - 265.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
P. V. Prasad, J. Goldfarb, C. Sundaram, A. Priatna, W. Li, and R. R. Edelman
Captopril MR Renography in a Swine Model: Toward a Comprehensive Evaluation of Renal Arterial Stenosis
Radiology, December 1, 2000; 217(3): 813 - 818.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1990 by the Society of Nuclear Medicine.